Suppr超能文献

23G玻璃体切割术治疗玻璃体视网膜疾病的疗效

Outcomes of 23-gauge pars plana vitrectomy in vitreoretinal diseases.

作者信息

Akçay Betül İlkay Sezgin, Uyar Osman Murat, Akkan Fevzi, Eltutar Kadir

机构信息

Ümraniye Training and Research Hospital, İstanbul, Turkey.

出版信息

Clin Ophthalmol. 2011;5:1771-6. doi: 10.2147/OPTH.S23910. Epub 2011 Dec 14.

Abstract

PURPOSE

The aim of this study was to assess the efficiency and reliability of the 23-gauge (23G) transconjunctival vitrectomy system and examine possible complications of this surgical technique in a variety of vitreoretinal conditions along with early postoperative intraocular pressure (IOP) changes.

MATERIALS AND METHODS

A total of 350 eyes of 324 patients having undergone 23G transconjunctival vitrectomy were included in this prospective study. A total of 150 (46.2%) were male and 174 (53.8%) female, with a mean age of 61.28 ± 15.67 years. Mean follow-up time was 8.3 months.

RESULTS

Mean BCVA logMARs were as follows: preoperatively 0.839 ± 0.59, postoperatively first day 2.07 ± 0.76, first week 1.14 ± 0,43, first month 0.63 ± 0.26 and last examination 0.359 ± 0.17. Mean BCVA decreased significantly (P < 0.001, P < 0.028, respectively) on postoperative first day and first week, mainly due to air or gas tamponade, and increased significantly in the first month and final control in almost all indications (P < 0.001). Postoperative mild hypotony (IOP ≤ 10 mmHg) was detected in 112 (32%) eyes on day 1 and in 59 (16.8%) eyes in week 1. While postoperative serious hypotony (≤ 5 mmHg) was detected in 34 (9.7%) eyes on day 1, it was not detected in any eyes at the end of the first week. None of the eyes required an additional gas tamponade or any other procedure in the early postoperative period due to hypotony. A total of 13 (3.7%) eyes were reoperated for recurrent vitreous hemorrhage; 23 (6.5%) eyes were reoperated on a second time, nine (2.5%) a third time, and 1 (0.2%) a fourth time for recurrent rhegmatogenous retinal detachment. Postoperative fibrinoid reaction was seen in 17 (4.8%) eyes on the first day and responded well to the medications. Cataract development was found in 61 (22.5%) of the 270 phakic eyes after a mean duration of 6.4 ± 3.5 months. Anatomical success was obtained in 86% of the patients and functional success in 72%.

CONCLUSION

The 23G transconjunctival vitrectomy system is safe and effective in a wide field of vitreoretinal conditions. It is a good alternative to 20G and 25G techniques but needs some improvement mainly in regards to the instruments and related techniques; further larger controlled group studies are needed.

摘要

目的

本研究旨在评估23号(23G)经结膜玻璃体切除术系统的效率和可靠性,并研究该手术技术在各种玻璃体视网膜疾病中的可能并发症以及术后早期眼压(IOP)变化。

材料与方法

本前瞻性研究纳入了324例接受23G经结膜玻璃体切除术的患者的350只眼。其中男性150例(46.2%),女性174例(53.8%),平均年龄61.28±15.67岁。平均随访时间为8.3个月。

结果

平均最佳矫正视力(BCVA)的对数最小分辨角(logMAR)如下:术前0.839±0.59,术后第1天2.07±0.76,第1周1.14±0.43,第1个月0.63±0.26,最后一次检查时0.359±0.17。术后第1天和第1周平均BCVA显著下降(分别为P<0.001,P<0.028),主要是由于空气或气体填塞,而在第1个月和最终检查时,几乎所有病例的BCVA均显著提高(P<0.001)。术后第1天112只眼(32%)检测到轻度低眼压(IOP≤10 mmHg),第1周59只眼(16.8%)检测到。术后第1天34只眼(9.7%)检测到严重低眼压(≤5 mmHg),第1周未检测到。术后早期没有一只眼因低眼压需要额外的气体填塞或任何其他手术。共有13只眼(3.7%)因复发性玻璃体出血再次手术;23只眼(6.5%)因复发性孔源性视网膜脱离第二次手术,9只眼(2.5%)第三次手术,1只眼(0.2%)第四次手术。术后第1天17只眼(4.8%)出现纤维蛋白样反应,药物治疗反应良好。270只晶状体眼中有61只(22.5%)在平均6.4±3.5个月后发生白内障。86%的患者获得解剖学成功,72%的患者获得功能成功。

结论

23G经结膜玻璃体切除术系统在广泛的玻璃体视网膜疾病中安全有效。它是20G和25G技术的良好替代方案,但主要在器械和相关技术方面需要一些改进;需要进一步开展更大规模的对照研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ace/3258085/efdcbc98dce4/opth-5-1771f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验